{"slideshow_credits": null, "snippet": "Forest Laboratories is acquiring Aptalis, a privately held maker of treatments for cystic fibrosis and gastrointestinal disorders.", "abstract": "Forest Laboratories is acquiring Aptalis, a privately held maker of treatments for cystic fibrosis and gastrointestinal disorders.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Dealbook", "role": "reported", "rank": 1, "organization": ""}], "original": "By DEALBOOK"}, "web_url": "http://dealbook.nytimes.com/2014/01/08/forest-labs-to-buy-specialty-drug-maker-for-2-9-billion/", "lead_paragraph": null, "headline": {"main": "Forest Labs to Buy Specialty Drug Maker for $2.9 Billion", "print_headline": "Buying a Peer", "kicker": "DealBook"}, "_id": "52cd6b6e38f0d878bab480f6", "word_count": "198", "multimedia": [], "pub_date": "2014-01-08T10:12:23Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "Forest Laboratories Inc", "rank": "2"}, {"name": "organizations", "value": "TPG Capital", "rank": "3"}, {"name": "organizations", "value": "Axcan Pharma Incorporated", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}